132 related articles for article (PubMed ID: 30558693)
1. Potential clinical applications of circulating cell-free DNA in ovarian cancer patients.
Barbosa A; Peixoto A; Pinto P; Pinheiro M; Teixeira MR
Expert Rev Mol Med; 2018 Dec; 20():e6. PubMed ID: 30558693
[TBL] [Abstract][Full Text] [Related]
2. Circulating tumor DNA in liquid biopsy: Current diagnostic limitation.
Liu SC
World J Gastroenterol; 2024 Apr; 30(15):2175-2178. PubMed ID: 38681986
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic and Prognostic Value of Circulating DNA Fragments in Glioblastoma Multiforme Patients.
Jarmuzek P; Wawrzyniak-Gramacka E; Morawin B; Tylutka A; Zembron-Lacny A
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673808
[TBL] [Abstract][Full Text] [Related]
4. Current Status of Circulating Tumor DNA Liquid Biopsy in Pancreatic Cancer.
Grunvald MW; Jacobson RA; Kuzel TM; Pappas SG; Masood A
Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33081107
[TBL] [Abstract][Full Text] [Related]
5. Efficient Capture and Isolation of Tumor-Related Circulating Cell-Free DNA from Cancer Patients Using Electroactive Conducting Polymer Nanowire Platforms.
Jeon S; Lee H; Bae K; Yoon KA; Lee ES; Cho Y
Theranostics; 2016; 6(6):828-36. PubMed ID: 27162553
[TBL] [Abstract][Full Text] [Related]
6. [Free circulating DNA as a tool for lung cancer patients management].
Tissot C; Villar S; Olivier M; Couraud S
Rev Pneumol Clin; 2016 Feb; 72(1):61-71. PubMed ID: 26190335
[TBL] [Abstract][Full Text] [Related]
7. Epigenetic modifications of cfDNA in liquid biopsy for the cancer care continuum.
Wong J; Muralidhar R; Wang L; Huang CC
Biomed J; 2024 Mar; ():100718. PubMed ID: 38522508
[TBL] [Abstract][Full Text] [Related]
8. The Impact of potential 'confounders' on the diagnostic sensitivity of circulating free DNA in management of FIT+ patients: a pilot study.
Scimia M; Pepe F; Russo G; Palumbo L; Malapelle U; Chuang R; Scimia S; Sha M; Tanaka H; Shen S; Chen D; Troncone G; Bianco MA
J Clin Pathol; 2024 Apr; ():. PubMed ID: 38649261
[TBL] [Abstract][Full Text] [Related]
9. Circulating Tumor Nucleic Acids: Perspective in Breast Cancer.
Casciano I; Vinci AD; Banelli B; Brigati C; Forlani A; Allemanni G; Romani M
Breast Care (Basel); 2010; 5(2):75-80. PubMed ID: 20847818
[TBL] [Abstract][Full Text] [Related]
10. Reply to "Circulating Tumor DNA Dynamics: A New Approach in Revolutionising Cancer Management," by Mavani, Parit et al.
Wang XY; Chen JH
Ann Surg Oncol; 2024 Jan; 31(1):165-166. PubMed ID: 37899410
[No Abstract] [Full Text] [Related]
11. Brain-derived cell-free DNA.
Southwood D; Singh S; Chatterton Z
Neural Regen Res; 2022 Oct; 17(10):2213-2214. PubMed ID: 35259835
[No Abstract] [Full Text] [Related]
12. Cell-Free DNA in the Liquid Biopsy Context: Role and Differences Between ctDNA and CTC Marker in Cancer Management.
Fici P
Methods Mol Biol; 2019; 1909():47-73. PubMed ID: 30580422
[TBL] [Abstract][Full Text] [Related]
13. Circulating Tumor Cells and Cell-Free DNA in Pancreatic Ductal Adenocarcinoma.
Gall TMH; Belete S; Khanderia E; Frampton AE; Jiao LR
Am J Pathol; 2019 Jan; 189(1):71-81. PubMed ID: 30558725
[TBL] [Abstract][Full Text] [Related]
14. Epigenetic Biomarkers in Cell-Free DNA and Applications in Liquid Biopsy.
Gai W; Sun K
Genes (Basel); 2019 Jan; 10(1):. PubMed ID: 30634483
[TBL] [Abstract][Full Text] [Related]
15. Circulating cell-free DNA release in vitro: kinetics, size profiling, and cancer-related gene methylation.
Panagopoulou M; Karaglani M; Balgkouranidou I; Pantazi C; Kolios G; Kakolyris S; Chatzaki E
J Cell Physiol; 2019 Aug; 234(8):14079-14089. PubMed ID: 30618174
[TBL] [Abstract][Full Text] [Related]
16. Cell-Free DNA in Pediatric Rhabdomyosarcoma: Potential and Challenges.
Tombolan L; Zin A; Bisogno G
Methods Mol Biol; 2019; 1909():165-175. PubMed ID: 30580430
[TBL] [Abstract][Full Text] [Related]
17. Quantitative Methylation-Specific PCR: A Simple Method for Studying Epigenetic Modifications of Cell-Free DNA.
Sigalotti L; Covre A; Colizzi F; Fratta E
Methods Mol Biol; 2019; 1909():137-162. PubMed ID: 30580429
[TBL] [Abstract][Full Text] [Related]
18. Head and Neck Squamous Cell Carcinoma Detection and Surveillance: Advances of Liquid Biomarkers.
Swiecicki PL; Brennan JR; Mierzwa M; Spector ME; Brenner JC
Laryngoscope; 2019 Aug; 129(8):1836-1843. PubMed ID: 30570748
[TBL] [Abstract][Full Text] [Related]
19. Liquid biopsy in ovarian cancer using circulating tumor DNA and cells: Ready for prime time?
Asante DB; Calapre L; Ziman M; Meniawy TM; Gray ES
Cancer Lett; 2020 Jan; 468():59-71. PubMed ID: 31610267
[TBL] [Abstract][Full Text] [Related]
20. Increased circulating tumor DNA as a noninvasive biomarker of early treatment response in patients with metastatic ovarian carcinoma: A pilot study.
Alves MC; Fonseca FLA; Yamada AMTD; Barros LADR; Lopes A; Silva LCFF; Luz AS; Melo Cruz FJS; Del Giglio A
Tumour Biol; 2020 May; 42(5):1010428320919198. PubMed ID: 32364828
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
